Nicole White
Corporate Officer/Principal bij ASSEMBLY BIOSCIENCES, INC.
Vermogen: 173 233 $ op 31-03-2024
Profiel
Nicole S.
White is currently the Chief Manufacturing Officer at Assembly Biosciences, Inc. She started this position in 2022.
Prior to her current role, she worked at Gossamer Bio, Inc. as the Senior Director & Head-Process Chemistry from 2019 to 2020.
Before that, she was the Director-CMC at Abide Therapeutics, Inc. from 2017 to 2018.
Nicole's earliest position was as a Principal at Gilead Sciences, Inc. from 2009 to 2015.
She holds a doctorate degree from the University of California, Irvine and an undergraduate degree from the University of California San Diego.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-04-2024 | 13 025 ( 0.24% ) | 173 233 $ | 31-03-2024 |
Actieve functies van Nicole White
| Bedrijven | Functie | Begin |
|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Corporate Officer/Principal | 17-11-2020 |
Eerdere bekende functies van Nicole White
| Bedrijven | Functie | Einde |
|---|---|---|
| GOSSAMER BIO, INC. | Corporate Officer/Principal | 01-11-2020 |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-04-2018 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-10-2015 |
Opleiding van Nicole White
| University of California, Irvine | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Abide Therapeutics, Inc.
Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Health Technology |
